Susceptibility to ATP depletion of primary proximal tubular cell cultures derived from mice lacking either the α1 or the α2 isoform of the catalytic domain of AMPK

BMC Nephrology

Jerrold S Levine²  Vimal Patel²  Benoit Viollet³  Leiqing Zhang¹  Meiyi Tang¹  Wilfred Lieberthal¹ 

[1]Northport Veterans Affairs Medical Center, Northport, NY 11768, USA

[2]Jesse Brown Veterans Affairs Medical Center, Chicago, IL 60612, USA

[3]Université Paris Descartes, Sorbonne Paris Cité, Paris, France

关键词: Antimycin;    Metabolic stress;    ATP depletion;    shRNA;    Apoptosis knockout mice;    Survival;    Viability;    AMPK;   

Others  :  1082788
DOI  :  10.1186/1471-2369-14-251

 received in 2013-05-30, accepted in 2013-11-06,  发布年份 2013

【 摘 要 】

Background

The purpose of this study was to determine whether AMPK influences the survival of primary cultures of mouse proximal tubular (MPT) cells subjected to metabolic stress. Previous studies, using an immortalized MPT cell line, suggest that AMPK is activated during metabolic stress, and ameliorates stress-induced apoptosis of these cells.

Methods

Primary MPT cells were cultured from AMPK knockout (KO) mice lacking either the α1 or the α2 isoform of the catalytic domain of AMPK. MPT cells were subjected to ATP depletion using antimycin A.

Results

Surprisingly, there was no difference in the amount of death induced by metabolic stress of MPT cells from either type of AMPK KO mice compared to its WT control. Moreover, inhibition of the activity of the α1 isoform in primary MPT cells from α2^-/- mice (pharmacologically, via compound C) or inhibition of the α2 isoform in primary MPT cells from α1^-/- mice (molecularly, via knockdown) both decreased cell viability equivalently in response to metabolic stress. The explanation for this unexpected result appears to be an adaptive increase in expression of the non-deleted α-isoform. As a consequence, total α-domain expression (i.e. α1 + α2), is comparable in kidney cortex and in cultured MPT cells derived from either type of KO mouse versus its WT control. Importantly, each α-isoform appears able to compensate fully for the absence of the other, with respect to both the phosphorylation of downstream targets of AMPK and the amelioration of stress-induced cell death.

Conclusions

These findings not only confirm the importance of AMPK as a pro-survival kinase in MPT cells during metabolic stress, but also show, for the first time, that each of the two α-isoforms can substitute for the other in MPT cells from AMPK KO mice with regard to amelioration of stress-induced loss of cell viability.

【 授权许可】

   
2013 Lieberthal et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 2.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

【 参考文献 】

• [1]Hardie DG, Ross FA, Hawley SA: AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012, 13(4):251-262.
• [2]Steinberg GR, Kemp BE: AMPK in health and disease. Physiol Rev 2009, 89(3):1025-1078.
• [3]Hardie DG: Signal transduction: how cells sense energy. Nature 2011, 472(7342):176-177.
• [4]Bland ML, Birnbaum MJ: Cell biology. ADaPting to energetic stress. Science 2011, 332(6036):1387-1388.
• [5]Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, et al.: LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003, 13(22):2004-2008.
• [6]Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV, Carmena D, et al.: Structure of mammalian AMPK and its regulation by ADP. Nature 2011, 472(7342):230-233.
• [7]Oakhill JS, Steel R, Chen ZP, Scott JW, Ling N, Tam S, et al.: AMPK is a direct adenylate charge-regulated protein kinase. Science 2011, 332(6036):1433-1435.
• [8]Carling D: The AMPK-activated protein kinase cascade - a unifying system for energy control. Trends Biochem Sci 2004, 29:18-24.
• [9]Hardie DG: AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 2007, 8(10):774-785.
• [10]Hardie DG, Carling D: The AMP-activated protein kinase–fuel gauge of the mammalian cell? Eur J Biochem 1997, 246(2):259-273.
• [11]Hardie DG: AMP-activated protein kinase: the guardian of cardiac energy status. J Clin Invest 2004, 114(4):465-468.
• [12]Hallows KR, Mount PF, Pastor-Soler NM, Power DA: Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am J Physiol Renal Physiol 2010, 298:F1067-F1077.
• [13]Hue L, Beauloye C, Bertrand L, Horman S, Krause U, Marsin AS, et al.: New targets of AMP-activated protein kinase. Biochem Soc Trans 2003, 31(Pt 1):213-215.
• [14]Hardie DG, Carling D, Carlson M: The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998, 67:821-855.
• [15]Hardie DG, Pan DA: Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 2002, 30(Pt 6):1064-1070.
• [16]Hay N, Sonenberg N: Upstream and downstream of mTOR. Genes Dev 2004, 18(16):1926-1945.
• [17]Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, et al.: AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008, 30(2):214-226.
• [18]Lieberthal W, Zhang L, Patel VA, Levine JS: AMPK protects proximal tubular cells from stress-induced apoptosis by an ATP-independent mechanism: potential role of Akt activation. Am J Physiol Renal Physiol 2011, 301(6):F1177-F1192.
• [19]Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, Flamez D, et al.: The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 2003, 111(1):91-98.
• [20]Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, et al.: Knockout of the alpha2 but not alpha1 5’-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 2004, 279(2):1070-1079.
• [21]Kroshian VM, Sheridan AM, Lieberthal W: Functional and cytoskeletal changes induced by sublethal injury in proximal tubular epithelial cells. Am J Physiol 1994, 266(1 Pt 2):F21-F30.
• [22]Lieberthal W, Menza SA, Levine JS: Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 1998, 274(2 Pt 2):F315-F327.
• [23]Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, et al.: Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol 2005, 288(4):F703-F713.
• [24]Gruzman A, Babai G, Sasson S: Adenosine monophosphate-activated protein kinase (AMPK) as a New target for antidiabetic drugs: a review on metabolic, pharmacological and chemical considerations. Rev Diabet Stud 2009, 6(1):13-36.
• [25]Mori H, Inoki K, Masutani K, Wakabayashi Y, Komai K, Nakagawa R, et al.: The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun 2009, 384(4):471-475.
• [26]Luo Z, Saha AK, Xiang X, Ruderman NB: AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 2005, 26(2):69-76.
• [27]Kola B, Boscaro M, Rutter GA, Grossman AB, Korbonits M: Expanding role of AMPK in endocrinology. Trends Endocrinol Metab 2006, 17(5):205-215.
• [28]Musi N, Goodyear LJ: Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2002, 2(2):119-127.
• [29]Kato K, Ogura T, Kishimoto A, Minegishi Y, Nakajima N, Miyazaki M, et al.: Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 2002, 21(39):6082-6090.
• [30]Arad M, Seidman CE, Seidman JG: AMP-activated protein kinase in the heart: role during health and disease. Circ Res 2007, 100(4):474-488.
• [31]Russell RR 3rd, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, et al.: AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004, 114(4):495-503.
• [32]Spector NL, Yarden Y, Smith B, Lyass L, Trusk P, Pry K, et al.: Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells. Proc Natl Acad Sci U S A 2007, 104(25):10607-10612.
• [33]Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, et al.: Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 2005, 11(10):1096-1103.
• [34]Terai K, Hiramoto Y, Masaki M, Sugiyama S, Kuroda T, Hori M, et al.: AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 2005, 25(21):9554-9575.
• [35]Peralta C, Bartrons R, Serafin A, Blazquez C, Guzman M, Prats N, et al.: Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001, 34(6):1164-1173.
• [36]Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD: Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 2007, 38(11):2992-2999.
• [37]McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV: Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005, 280(21):20493-20502.
• [38]Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A, et al.: AMP-activated protein kinase contributes to UV- and H2O2-induced apoptosis in human skin keratinocytes. J Biol Chem 2008, 283(43):28897-28908.
• [39]Memmott RM, Gills JJ, Hollingshead M, Powers MC, Chen Z, Kemp B, et al.: Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells. Cancer Res 2008, 68(2):580-588.
• [40]Okoshi R, Ozaki T, Yamamoto H, Ando K, Koida N, Ono S, et al.: Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress. J Biol Chem 2008, 283(7):3979-3987.
• [41]Shaw MM, Gurr WK, McCrimmon RJ, Schorderet DF, Sherwin RS: 5’AMP-activated protein kinase alpha deficiency enhances stress-induced apoptosis in BHK and PC12 cells. J Cell Mol Med 2007, 11(2):286-298.
• [42]Tzatsos A, Tsichlis PN: Energy depletion inhibits phosphatidylinositol 3-kinase/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794. J Biol Chem 2007, 282(25):18069-18082.
• [43]Dagon Y, Avraham Y, Berry EM: AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun 2006, 340(1):43-47.